001     309600
005     20260202120628.0
024 7 _ |a 10.1016/j.esmogo.2025.100297
|2 doi
037 _ _ |a DKFZ-2026-00250
082 _ _ |a 610
100 1 _ |a Stelmach, R.
|b 0
245 _ _ |a Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial
260 _ _ |a [Amsterdam]
|c 2026
|b Elsevier B.V.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1770021971_1557479
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:D120#
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Lorenzen, S.
|b 1
700 1 _ |a Ettrich, T. J.
|b 2
700 1 _ |a Longo, F. R.
|0 0000-0003-0902-2188
|b 3
700 1 _ |a Chibaudel, B.
|0 0000-0003-1279-2044
|b 4
700 1 _ |a Greil, R.
|b 5
700 1 _ |a Perwög, M.
|0 0000-0002-9153-5179
|b 6
700 1 _ |a Larcher-Steiner, J.
|b 7
700 1 _ |a Jäger, D.
|0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
|b 8
|u dkfz
700 1 _ |a Lordick, F.
|0 0000-0001-8591-9339
|b 9
700 1 _ |a Stocker, G.
|0 0009-0002-5999-6351
|b 10
700 1 _ |a Haag, Georg Martin
|0 P:(DE-He78)f54d0426f2215c539d3a7ae1b400b57d
|b 11
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.esmogo.2025.100297
|g Vol. 11, p. 100297 -
|0 PERI:(DE-600)3188250-X
|p 100297
|t ESMO gastrointestinal oncology
|v 11
|y 2026
|x 2949-8198
909 C O |o oai:inrepo02.dkfz.de:309600
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)f54d0426f2215c539d3a7ae1b400b57d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2026
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-05
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-07-04T13:07:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-07-04T13:07:21Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-07-04T13:07:21Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-11-05
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-11-05
920 2 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21